Haleon (NYSE:HLN) Price Target Raised to $10.95

Haleon (NYSE:HLN) had its price objective lifted by Morgan Stanley from $9.90 to $10.95 in a report released on Friday morning, Benzinga reports. They currently have an overweight rating on the stock.

Other research analysts have also issued reports about the company. The Goldman Sachs Group lowered Haleon from a buy rating to a neutral rating in a research report on Tuesday, August 6th. Berenberg Bank started coverage on Haleon in a research note on Tuesday, August 6th. They issued a buy rating on the stock. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Haleon presently has a consensus rating of Moderate Buy and an average target price of $10.95.

Haleon Stock Up 0.6 %

Shares of NYSE:HLN opened at $10.52 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The firm has a market cap of $48.04 billion, a price-to-earnings ratio of 35.07, a PEG ratio of 3.10 and a beta of 0.26. The stock’s 50-day moving average price is $9.76 and its two-hundred day moving average price is $8.88. Haleon has a 12-month low of $7.70 and a 12-month high of $10.76.

Haleon (NYSE:HLN) last released its earnings results on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). The company had revenue of $3.50 billion during the quarter, compared to analyst estimates of $3.55 billion. Haleon had a return on equity of 13.15% and a net margin of 9.71%. During the same period in the prior year, the business posted $0.08 earnings per share. On average, research analysts forecast that Haleon will post 0.46 EPS for the current year.

Haleon Cuts Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 19th. Investors of record on Friday, August 16th were given a dividend of $0.0514 per share. The ex-dividend date was Friday, August 16th. This represents a yield of 1.6%. Haleon’s dividend payout ratio (DPR) is 33.33%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in HLN. Sanctuary Advisors LLC acquired a new stake in shares of Haleon in the second quarter valued at about $1,658,000. Clearbridge Investments LLC grew its position in Haleon by 8.6% in the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock valued at $344,888,000 after acquiring an additional 3,307,009 shares in the last quarter. Truist Financial Corp raised its stake in shares of Haleon by 4.9% during the second quarter. Truist Financial Corp now owns 757,133 shares of the company’s stock valued at $6,254,000 after purchasing an additional 35,456 shares during the period. Wallace Advisory Group LLC lifted its position in shares of Haleon by 30.1% during the second quarter. Wallace Advisory Group LLC now owns 18,086 shares of the company’s stock worth $149,000 after purchasing an additional 4,188 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of Haleon by 12.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 13,281 shares of the company’s stock valued at $110,000 after purchasing an additional 1,450 shares during the period. 6.67% of the stock is owned by hedge funds and other institutional investors.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.